Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

817
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
817
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.3K
Hormonal Regulation01:33

Hormonal Regulation

33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.8K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Increasing the number of surgically cured primary aldosteronism patients: The promise of simplified diagnosis and advanced nuclear adrenocortical imaging.

American journal of surgery·2023
Same author

Automated Item Generation: impact of item variants on performance and standard setting.

BMC medical education·2023
Same author

Early Dalmatian farmers specialized in sheep husbandry.

Scientific reports·2023
Same author

Novel imaging techniques in refractory pituitary adenomas.

Pituitary·2023
Same author

Secondary amenorrhoea with absent axillary hair.

European journal of internal medicine·2023
Same author

The influence of candidates' physical attributes on patient ratings in simulated assessments of clinical practice.

Medical teacher·2022
Same journal

Efficacy and Safety of Baxdrostat in the Management of Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

American journal of hypertension·2026
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
Ver todos los artículos relacionados

Video Experimental Relacionado

Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K

¿Es hora de retirar las pruebas de confirmación para el aldosteronismo primario?

G A Kline1, A A Leung1, D Orton2

  • 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.

American journal of hypertension
|September 1, 2025
PubMed
Resumen
Este resumen es generado por máquina.

El diagnóstico del aldosteronismo primario (AP) mediante pruebas de supresión de aldosterona no es confiable debido al espectro bioquímico, la variabilidad del ensayo y la fisiopatología multifactorial. La evidencia actual sugiere retirar estas pruebas tradicionales para el diagnóstico de la AP.

Palabras clave:
HipertensiónAldosterona y sus derivadosAldosteronismo primariohipertensión secundaria

Más Videos Relacionados

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

23.6K
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

8.2K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.7K

Área de la Ciencia:

  • Endocrinología
  • Investigación de la hipertensión
  • Medicina de diagnóstico

Sus antecedentes:

  • El aldosteronismo primario (AP) es la causa más común de hipertensión endocrina.
  • El diagnóstico se basa tradicionalmente en las pruebas de supresión de la aldosterona, evaluando la vía renina-angiotensina-aldosterona.
  • Estas pruebas han sido estándar durante décadas basadas en estudios fisiopatológicos tempranos.

Objetivo del estudio:

  • Evaluar críticamente la utilidad diagnóstica de las pruebas tradicionales de supresión de la aldosterona para la AP.
  • Para resaltar la evidencia moderna que cuestiona la validez y la confiabilidad de estas pruebas.
  • Proponer una reevaluación de las estrategias de diagnóstico de la AP.

Principales métodos:

  • Revisión de la comprensión moderna de la fisiopatología de la PA.
  • Evaluación crítica de los estudios de pruebas de diagnóstico, incluidos los metanálisis.
  • Análisis de un reciente estudio prospectivo y a ciegas sobre pruebas de supresión salina.

Principales resultados:

  • Las pruebas de supresión se enfrentan a desafíos: espectro bioquímico continuo, incertidumbre del ensayo de aldosterona, fisiopatología de PA multifactorial y sesgos del estudio.
  • Un estudio reciente mostró que las pruebas de supresión salina carecían de discriminación diagnóstica.
  • Los metanálisis indican una sobreestimación del valor diagnóstico debido a sesgos y factores de confusión.

Conclusiones:

  • Las pruebas tradicionales de supresión de la aldosterona son científicamente inadecuadas para el diagnóstico de AP o la definición de la enfermedad.
  • La naturaleza continua de la PA y las limitaciones del ensayo hacen que los umbrales de diagnóstico únicos sean inválidos.
  • La evidencia apoya el retiro de las pruebas de supresión y la exploración de nuevos enfoques de diagnóstico para la AP.